Chronic Migraine Clinical Trial
— NEUROMIGOfficial title:
Comparison Between Stimulation Transcranial Protocols With Continuous Current in the Chronic Migraine: Clinical Trial, Triple-blind, Placebo-controlled
Verified date | August 2019 |
Source | Federal University of Paraíba |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study aims to compare the effects of transcranial direct current stimulation on the clinical and cognitive function in patients with chronic migraine.
Status | Completed |
Enrollment | 31 |
Est. completion date | February 16, 2018 |
Est. primary completion date | February 5, 2018 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 20 Years to 45 Years |
Eligibility |
Inclusion Criteria: - females - clinical diagnosis of chronic migraine according to the International Classification of Headaches Disorders (ICHD-3 beta). Exclusion Criteria: - headache attributable to some pathological condition, associated neurologic or neuropsychiatric disease - use of central nervous system modulating drugs - pregnancy - metallic head implants - use of a cardiac pacemaker |
Country | Name | City | State |
---|---|---|---|
Brazil | Federal University of Paraiba | João Pessoa | Paraiba |
Lead Sponsor | Collaborator |
---|---|
Federal University of Paraíba |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Migraine Disability Assessment - MIDAS | Change in perform activities of daily living associate to migraine assessed on the Migraine Disability Assessment - MIDAS. | "before treatment", "after treatment - up to 2 weeks " and "up to 1 month after the last day of treatment" | |
Secondary | Headache Impact Test - HIT-6 | Change in quality of life associate to migraine assessed on the Headache Impact Test-6 (HIT-6) | "before treatment", "after treatment - up to 2 weeks " and "up to 1 month after the last day of treatment" | |
Secondary | Wechsler Intelligence Scale Letters | Change in cognitive ability assessed on the Wechsler Adult Intelligence Scale Letters | "before treatment", "after treatment - up to 2 weeks " and "up to 1 month after the last day of treatment" | |
Secondary | Wechsler Intelligence Scale Numbers Test | Change in cognitive ability assessed on the Wechsler Adult Intelligence Scale Numbers Test | "before treatment", "after treatment - up to 2 weeks " and "up to 1 month after the last day of treatment" | |
Secondary | Hayling's Test Hayling's Test | Change in operational memory assessed on the Hayling's Test Evaluate operational memory | "before treatment", "after treatment - up to 2 weeks " and "up to 1 month after the last day of treatment" | |
Secondary | Trail Making Test part B | Change in executive functions assessed on the Trail Making Test part B | "before treatment", "after treatment - up to 2 weeks " and "up to 1 month after the last day of treatment" | |
Secondary | Salthouse Visual Patterns and Lyrics | Change in visual processing speed assessed on the Salthouse Visual Patterns and Lyrics | "before treatment", "after treatment - up to 2 weeks " and "up to 1 month after the last day of treatment" | |
Secondary | Nine Hole Peg Test | Change in the motor processing speed assessed on the Nine Hole Peg Test | "before treatment", "after treatment - up to 2 weeks " and "up to 1 month after the last day of treatment" | |
Secondary | Paced Auditory Serial Addition Task | Change in selective attention assessed on the Paced Auditory Serial Addition Task | "before treatment", "after treatment - up to 2 weeks " and "up to 1 month after the last day of treatment" | |
Secondary | Concentrated Attention Test | Change in selective attention assessed on the Concentrated Attention Test | "before treatment", "after treatment - up to 2 weeks " and "up to 1 month after the last day of treatment" | |
Secondary | Visual Attention Test (Attention Matrices) | Change in selective attention assessed on the Visual Attention Test (Attention Matrices) | "before treatment", "after treatment - up to 2 weeks " and "up to 1 month after the last day of treatment" | |
Secondary | Montreal Cognitive Assessment | Change in cognition assessed on the Montreal Cognitive Assessment | "before treatment", "after treatment - up to 2 weeks " and "up to 1 month after the last day of treatment" | |
Secondary | Side Effects Questionnaire | adverse effects assessment | "every day for up to 2 weeks" |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05720819 -
Biofeedback-VR for Treatment of Chronic Migraine
|
N/A | |
Not yet recruiting |
NCT06428838 -
Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context
|
Phase 3 | |
Recruiting |
NCT05517200 -
Pilot Study for a Machine Learning Test for Migraine
|
||
Recruiting |
NCT05891808 -
miR-155 Expression in Episodic and Chronic Migraine
|
||
Completed |
NCT02514148 -
Biobehavioral Physical Therapy Strategies Based on Therapeutic Exercise Applied to Chronic Migraine Patients
|
N/A | |
Enrolling by invitation |
NCT02291380 -
A Study to Evaluate Botulinum Toxin Type A for Injection(HengLi®)for Prophylactic Treatment of Chronic Migraine
|
Phase 3 | |
Completed |
NCT02122237 -
Cathodal tDCS in Chronic Migraine: Neurophysiological Study and Pilot Therapeutic Trial
|
Phase 3 | |
Withdrawn |
NCT02122744 -
RCT Versus Placebo of rTMSQP Over Visual Cortex for the Prevention of Chronic Migraine
|
N/A | |
Recruiting |
NCT02202486 -
Investigation of the Blood-brain and Blood-dura Barrier Durin Migraine Attacks Using MRI
|
N/A | |
Completed |
NCT01709708 -
Use of the Tx360 Nasal Applicator in the Treatment of Chronic Migraine
|
Phase 4 | |
Completed |
NCT01741246 -
Neuroimaging Studies of Chronic Primary Headaches Using Positron Emission Tomography and Magnetic Resonance Imaging
|
N/A | |
Completed |
NCT01090050 -
Treximet in the Treatment of Chronic Migraine
|
Phase 4 | |
Recruiting |
NCT03507400 -
Introvision for Migraine and Headaches
|
N/A | |
Completed |
NCT04161807 -
Efficacy and Safety of Nerivio™ for Acute Treatment of Migraine in People With Chronic Migraine
|
N/A | |
Completed |
NCT03175263 -
OnabotulinumtoxinA Injections in Chronic Migraine, Targeted to Sites of Pericranial Myofascial Pain
|
N/A | |
Withdrawn |
NCT04353505 -
Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headache
|
Phase 1 | |
Completed |
NCT01667250 -
Non-Invasive Neurostimulation for the Prevention of Chronic Migraine
|
N/A | |
Completed |
NCT01700387 -
A Study to Evaluate the Tolerability of Botox and Topiramate or Botox and Placebo and Effect on Cognitive Efficiency
|
Phase 4 | |
Not yet recruiting |
NCT01135784 -
Study of MIGRA-ZEN RELIEF PLUS In the Treatment of Chronic Migraine Headache
|
Phase 2 | |
Completed |
NCT00772031 -
NINDS CRC Chronic Migraine Treatment Trial
|
Phase 3 |